Harrow to Present at Two Investor Conferences in May
Harrow (Nasdaq: HROW), a prominent North American eyecare pharmaceutical company, will participate in two investor conferences in May. The company will attend the B. Riley Securities 24th Annual Institutional Investor Conference at the Beverly Hilton Hotel in Beverly Hills, CA, on May 22-23, 2024. The event includes an in-person Fireside Chat and 1x1 investor meetings.
Harrow will also be present at the Craig-Hallum 21st Annual Institutional Investor Conference at the Depot Renaissance Hotel in Minneapolis, MN, on May 29, 2024, featuring 1x1 and small group investor meetings. Interested investors should contact their B. Riley or Craig-Hallum representative for meeting arrangements. Neither event will be webcast.
- Harrow's participation in two major investor conferences may enhance visibility and investor confidence.
- Engagements through Fireside Chats, 1x1, and small group meetings provide direct interaction with potential investors.
- Being featured in well-known conferences like B. Riley Securities and Craig-Hallum can positively impact investor relations.
- Neither of the investor conferences will be webcast, limiting broader investor access to real-time insights and information.
- There is no mention of new product announcements or financial updates, which may be anticipated by investors.
B. Riley Securities 24th Annual Institutional Investor Conference (Beverly Hilton Hotel,
Format: Fireside Chat (In-Person), followed by 1x1 Investor Meetings
Date/Time: Wednesday, May 22, 2024, through Thursday, May 23, 2024
Craig-Hallum 21st Annual Institutional Investor Conference (Depot Renaissance Hotel,
Format: 1x1 and Small Group Investor Meetings
Date/Time: Wednesday, May 29, 2024
Investors interested in meeting with management during either conference should contact their B. Riley or Craig-Hallum representative to request a meeting. Neither event will be webcast.
About Harrow
Harrow, Inc. (Nasdaq: HROW) is a leading eyecare pharmaceutical company engaged in the discovery, development, and commercialization of innovative ophthalmic pharmaceutical products for the North American market. Harrow helps eyecare professionals preserve the gift of sight by making its portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of patients each year. For more information about Harrow, please visit harrow.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20240515334076/en/
Jamie Webb, Director of Communications and Investor Relations
jwebb@harrowinc.com
615-733-4737
Source: Harrow, Inc.
FAQ
When will Harrow present at the B. Riley Securities 24th Annual Institutional Investor Conference?
What is the format of Harrow's participation at the B. Riley Securities 24th Annual Institutional Investor Conference?
Where is the B. Riley Securities 24th Annual Institutional Investor Conference held?
When is the Craig-Hallum 21st Annual Institutional Investor Conference?
What activities will Harrow engage in at the Craig-Hallum 21st Annual Institutional Investor Conference?
Where will the Craig-Hallum 21st Annual Institutional Investor Conference take place?
Will Harrow's presentations at the investor conferences be webcast?
How can investors arrange meetings with Harrow's management during the conferences?
